Fentanyl Buccal Tablet (FBT)
C25608/4027/BP/EU
Approved small_molecule terminated
Quick answer
Fentanyl Buccal Tablet (FBT) for Cancer Pain is a Approved program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Cancer Pain
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated